Effect of TSH inhibition on sIL-2 R, TSGF, CD44 V6 and T lymphocyte subsets in elderly patients with thyroid cancer
- VernacularTitle:促甲状腺激素抑制疗法对老年甲状腺癌患者血清sIL－2 R、CD44 V6、TSGF及外周血T淋巴细胞亚群影响研究
- Author:
Weihong WU
;
Fengping WANG
- Publication Type:Journal Article
- Keywords:
TSH suppression therapy;
elderly thyroid cancer;
SIL-2R;
CD44V6;
TSGF;
T lymphocyte subsets
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;37(7):104-106
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the effect of TSH inhibition on soluble interleukin 2 receptor ( sIL-2R), interleukin 44 variant 6 (CD44V6), tumor specific growth factor (TSGF) and T lymphocyte subsets in elderly patients with thyroid cancer.Methods 50 elderly patients with thyroid cancer in our hospital were collected.The patients were randomly assigned to experimental and control groups, 25 cases in each group, patients in the experimental group were given TSH suppression therapy after surgery , patients in control group were given thyroxine replacement therapy after operation, treatment for 1 month, serum SIL-2R, CD44v6, TSGF and peripheral blood T lymphocyte subsets situation were detected in all patients with .ResuIts After treatment, compared with the control group, ①in the experimental group, the level of serum sIL-2R was significantly lower, the difference was statistically significant(P<0.05);②the serum CD44V6 level was lower in the experimental group (P<0.05);③the serum TSGF level was lower in the experimental group (P<0.05);③in the experimental group,the levels of CD3 + and CD4 +were higher, levels of CD8 + were lower ( P<0.05 ) .ConcIusions TSH suppression therapy can reduce senile thyroid cancer patients serum SIL-2R, CD44v6, TSGF and CD8 +lymphocyte level, peripheral blood T lymphocyte CD3 +, CD4 +levels were elevated,and improve the immune function of patients , the clinical has guiding significance .
